All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

ME Fund seeks support for ResetME trial testing daratumumab as potential ME/CFS treatment

2d ago· 6 min readen

Summary

The ME Fund (ME-fondet), a Norwegian non-profit, is raising funds for the ResetME trial — a larger, controlled study of daratumumab (a monoclonal antibody originally developed for cancer) as a potential treatment for ME/CFS patients with post-exertional malaise (PEM). A promising pilot study showed encouraging results, but a larger trial with a control group is needed to verify or refute those findings. The article is a fundraising appeal to support biomedical research for this severe, currently untreatable disease.

Source

Twitter / XME Fund seeks support for ResetME trial testing daratumumab as potential ME/CFS treatmentme-foreningen.no

Key quotes

· 3 pulled
There is no approved, effective treatment for ME/CFS – but you could help us change that!
A pilot study with the monoclonal antibody daratumumab, an immune-system drug originally developed for cancer, has shown very promising results in a pilot study for ME/CFS patients with post exertional malaise (PEM).
Even though the pilot study is encouraging, a larger study with a control group is needed to verify or refute the results.
Snippet from the RSS feed
ME-fondet is a Norwegian non-profit foundation dedicated to supporting biomedical research on Myalgic Encephalomyelitis (ME/CFS). We raise funds for high-quality, independent studies that seek to uncover the underlying mechanisms of this severe disease an

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.